Haaretz
-
17:57 Sep 04, 2025
U.S. medical device giant Edwards Lifesciences acquired Vectorious for $497 million, after a 52 percent stake deal in 2023. Vectorious' tiny battery-free sensor, still in clinical trials, monitors heart pressure via an app. The Tel Aviv team will become Edwards' R&D center for implanted sensors